Sign In
Home
About Us
Benefits
Pricing
Templeton Apus
Krixos GmbH
Contact Us
Breaking Cancer News A-Z
Health/Pharma Companies
Drugs, Treatments, Trials
Hot Topics
Clinical Trials - Latest News
Other Illnesses & Conditions
Latest Healthcare News
My Settings
Client Requests
Advanced Search
My Viewed Articles
All Cancer News
Acute Lymphoblastic Leukemia
Acute myeloid leukemia
Adenocarcinoma
Adenoid Cystic Carcinoma
Adrenocortical Carcinoma
Anal Cancer
Anaplastic Astrocytoma
Angiosarcoma
Astrocytoma
Basal-Cell Carcinoma
Bladder Cancer
Brain Cancer
Breast Cancer
Cancer Cachexia
Carcinoma
Cervical Cancer
Childhood Cancer
Cholangiocarcinoma
Chronic Lymphocytic Leukemia
Chronic Myeloid Leukemia
Colorectal Adenocarcinoma
Colorectal Cancer
Craniopharyngioma
Endometrial Cancer
Ependymoma
Esophageal Cancer
Ewing's Sarcoma
Gallbladder Cancer
Germ Cell Tumors
Glioblastoma
Glioma
Hairy Cell Leukemia
Hepatocellular Carcinoma
Hodgkin Lymphoma
Kaposi's Sarcoma
Kidney & Renal Cancer
Laryngeal Cancer
Leukemia
Liver Cancer
Lung Adenocarcinoma
Lung Cancer
Lymphoma
Mantle Cell Lymphoma
MCRPC
Medulloblastoma
Melanoma
Meningioma
Mesothelioma
Metastatic Colon Cancer
Mouth Cancer
Multiple Myeloma
Myelodysplastic Syndrome
Myelofibrosis
Nasopharyngeal Carcinoma
Neuroblastoma
NMIBC
Non-Hodgkin Lymphoma
NSCLC
Oral Cancer
Oropharyngeal Cancer
Osteosarcoma
Ovarian Cancer
Pancreatic Adenocarcinoma
Pancreatic Cancer
Pancreatic Neuroendocrine Tumors
Penile Cancer
Pheochromocytoma
Prostate Cancer
Retinoblastoma
Rhabdomyosarcoma
Sarcoma
Sarcopenia
Skin Cancer
Small Cell Lung Cancer
Squamous Cell Carcinoma
Stomach (Gastric) Cancer
Synovial Sarcoma
Testicular Cancer
Thymic Carcinoma
Thymoma
Thyroid Cancer
Tongue Cancer
Uterine Cancer
Vulvar Cancer
Waldenstrom Macroglobulinemia
You need to login...
Enter your email:
Enter your password:
If you are not registered...
Subscribe to Cancer Stat:
Sign Up Now:
Your email:
or call us on: +43 (0)1 71 72 8 900
or email:
apus@templetonapus.com
Most viewed
1.
AbbVie Announces Positive Topline Results from Phase 2 LUMINOSITY Trial Evaluating Telisotuzumab-Vedotin (Teliso-V) for Patients with Previously Treated Non-Small Cell Lung Cancer (NSCLC)
2.
Already-licensed drugs could be trialed to potentially treat secondary brain cancer, new research finds
3.
Research highlights need for education to combat cancer in Appalachia
4.
Why men die younger than women
5.
Case Report: A complete pathologic response in pancreatic cancer with squamous cell differentiation
6.
Pancreatic Cancer Market revenue to reach USD 36 Billion by 2036, says Research Nester
7.
Can we crack this cancer's immune response?
8.
Pancreatic cancer triggers immune response, but disease-fighting T cells may not easily infiltrate PDAC tumors: Study
9.
SMFG names deputy Nakashima as group CEO after predecessor's death
10.
Pancreatic cancer: County Antrim man feels 'lucky to be alive'
Last updated at 21:41 GMT
Hot News Makers
Health/Pharma Companies
ImmunoGen
383700.49
AbbVie
64115.60
Humana
29549.84
NHS
25591.79
HBM Healthcare Investments
14521.44
Johnson & Johnson
12269.04
PRISM BioLab
8666.33
ObsEva
8397.90
OMRF
8027.07
Food & Drug Administration
7655.39
Last updated at 21:10 GMT